JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 114 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $142,820 | +143.6% | 77,200 | +46.2% | 0.00% | – |
| Q4 2022 | $58,626 | -74.2% | 52,816 | -45.5% | 0.00% | -100.0% |
| Q3 2022 | $227,000 | -43.7% | 96,974 | -27.1% | 0.00% | 0.0% |
| Q2 2022 | $403,000 | -8.8% | 133,085 | +104.3% | 0.00% | 0.0% |
| Q1 2022 | $442,000 | -83.4% | 65,138 | -79.6% | 0.00% | -83.3% |
| Q4 2021 | $2,660,000 | +60.6% | 318,551 | +42.9% | 0.01% | +50.0% |
| Q3 2021 | $1,656,000 | -18.2% | 222,903 | -25.1% | 0.00% | -20.0% |
| Q2 2021 | $2,024,000 | +107.8% | 297,629 | +213.8% | 0.01% | +66.7% |
| Q1 2021 | $974,000 | -10.0% | 94,849 | -23.5% | 0.00% | 0.0% |
| Q4 2019 | $1,082,000 | +481.7% | 123,919 | +121.8% | 0.00% | +200.0% |
| Q3 2019 | $186,000 | -60.5% | 55,861 | -41.3% | 0.00% | -50.0% |
| Q2 2019 | $471,000 | -61.1% | 95,134 | -51.3% | 0.00% | -50.0% |
| Q1 2019 | $1,211,000 | -10.6% | 195,258 | -51.4% | 0.00% | -20.0% |
| Q4 2018 | $1,355,000 | -35.1% | 401,932 | +25.2% | 0.01% | -16.7% |
| Q3 2018 | $2,087,000 | +34.0% | 321,069 | +58.0% | 0.01% | +20.0% |
| Q2 2018 | $1,557,000 | – | 203,229 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
| TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
| COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
| Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
| Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
| PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
| RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
| Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
| Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |